Showing results (151-160 of 314) with videos related to

Sort By:
Pageof 32
Cancer|March 30, 2011
Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?Antoine Brouquet, Michael J Overman, Scott Kopetz, et al.
Journal of the American College of Surgeons|March 5, 2021
Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver MetastasesMeredith C Mason, Ching-Wei D Tzeng, Hop S Tran Cao, et al.
Surgery|September 5, 2016
Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resectionGuillaume Passot, Jason W Denbo, Suguru Yamashita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcomeAntoine Brouquet, Eddie K Abdalla, Scott Kopetz, et al.
JAMA Oncology|June 16, 2017
Genomic Profiling of Small-Bowel AdenocarcinomaAlexa B Schrock, Craig E Devoe, Robert McWilliams, et al.
Gut|November 1, 2017
Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumabThibault Mazard, Piyaporn Boonsirikamchai, Michael J Overman, et al.
Annals of Surgery|September 13, 2012
Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastasesAndreas Andreou, Scott Kopetz, Dipen M Maru, et al.
Scientific Reports|August 9, 2020
Increased expression of secreted frizzled related protein 1 (SFRP1) predicts ampullary adenocarcinoma recurrenceLi-Chin Cheng, Ying- Jui Chao, Michael J Overman, et al.
ESMO Open|January 1, 2026
Immune checkpoint blockade in locally advanced rectal cancer with deficient DNA mismatch repair: retrospective multicenter experienceO E Emiloju, N R Foster, P Shah, et al.
Clinical Colorectal Cancer|October 14, 2009
Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injuryJulian H Slade, Mona L Alattar, David R Fogelman, et al.
Pageof 32